Foamix Pharmaceuticals Ltd. Debt Instrument, Fair Value Disclosure
Foamix Pharmaceuticals Ltd. had Debt Instrument, Fair Value Disclosure of $36.60 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFairValue · last filed 2020-03-12
- 2019-12-31: Debt Instrument, Fair Value Disclosure $36.60M.
- 2019-09-30: Debt Instrument, Fair Value Disclosure $15.10M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2019-12-31 | $36.60M 10-K · filed 2020-03-12 |
| 2019-09-30 | $15.10M 10-Q · filed 2019-11-12 |